Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Añadir filtros








Intervalo de año
1.
Arq. bras. cardiol ; 103(6,supl.2): 1-126, 12/2014. tab, graf
Artículo en Portugués | LILACS | ID: lil-732161
2.
J. venom. anim. toxins incl. trop. dis ; 13(2): 431-445, 2007. tab
Artículo en Inglés | LILACS | ID: lil-452840

RESUMEN

The intestinal microbiota consists of a qualitatively and quantitatively diverse range of microorganisms dynamically interacting with the host. It is remarkably stable with regard to the presence of microorganisms and their roles which, however, can be altered due to pathological conditions, diet composition, gastrointestinal disturbances and/or drug ingestion. The present review aimed at contributing to the discussion about changes in the intestinal microbiota due to HIV-1 infection, focusing on the triad infection-microbiota-nutrition as factors that promote intestinal bacterial imbalance. Intestinal microbiota alterations can be due to the HIV-1 infection as a primary factor or the pharmacotherapy employed, or they can be one of the consequences of the disease.


Asunto(s)
Humanos , VIH-1 , Infecciones por VIH/complicaciones , Intestinos/microbiología , Estado Nutricional
4.
J. venom. anim. toxins incl. trop. dis ; 11(2): 143-159, May-Aug. 2005. tab
Artículo en Inglés | LILACS | ID: lil-402362

RESUMEN

Highly active antiretroviral therapy (HAART) has been associated with the development of a clinical group and metabolic disorders such as peripheral lipodystrophy syndrome in AIDS. The aim of this study was to analyse the lipid profile, the clinical aspects, and the body composition of HIV-1 infected individuals treated with or without protease inhibitor (PI) during the highly active antiretroviral therapy. In total, 62 individuals were evaluated in this study; 15 healthy individuals (Control Group; CG), 11 HIV-1 infected individuals treated without antiretroviral therapy (Group 1: G1), 14 HIV-1 infected individuals treated with antiretroviral therapy plus protease inhibitor (Group 2: G2), and 11 HIV-1 infected individuals treated with antiretroviral therapy without protease inhibitor (Group 3: G3), mean age 35 years old. The time interval for G2 and G3 was greater than or equal to nine months. Patients receiving HAART with PI had significantly lower viral loads, hypertriglyceridemia, and low HDL levels (p<0.05). There were no differences between groups in relation to the lean body mass percentage obtained by mid-arm muscle circumference adequacy or by bioelectrical impedance. The lower percentage of body fat observed in all the HIV-1 infected patients by antropometric assessment and the decreased tricipital skinfold adequacy in the group treated with PI in relation to CG may suggest lipodystrophy in the upper limbs, especially on those treated with PI


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Composición Corporal , VIH-1 , Lípidos/fisiología , Retroviridae , Síndrome de Inmunodeficiencia Adquirida/fisiopatología , Síndrome de Inmunodeficiencia Adquirida/terapia
5.
Braz. j. med. biol. res ; 34(8): 971-975, Aug. 2001. ilus
Artículo en Inglés | LILACS | ID: lil-290144

RESUMEN

We have examined the role of cell surface glycosaminoglycans in cell division: adhesion and proliferation of Chinese hamster ovary (CHO) cells. We used both wild-type (CHO-K1) cells and a mutant (CHO-745) which is deficient in the synthesis of proteoglycans due to lack of activity of xylosyl transferase. Using different amounts of wild-type and mutant cells, little adhesion was observed in the presence of laminin and type I collagen. However, when fibronectin or vitronectin was used as substrate, there was an enhancement in the adhesion of wild-type and mutant cells. Only CHO-K1 cells showed a time-dependent adhesion on type IV collagen. These results suggest that the two cell lines present different adhesive profiles. Several lines of experimental evidence suggest that heparan sulfate proteoglycans play a role in cell adhesion as positive modulators of cell proliferation and as key participants in the process of cell division. Proliferation and cell cycle assays clearly demonstrate that a decrease in the amount of glycosaminoglycans does not inhibit the proliferation of mutant CHO-745 cells when compared to the wild type CHO-K1, in agreement with the findings that both CHO-K1 and CHO-745 cells take 8 h to enter the S phase


Asunto(s)
Animales , Cricetinae , Células CHO/citología , Matriz Extracelular/fisiología , Proteoglicanos de Heparán Sulfato/fisiología , Adhesión Celular/fisiología , División Celular , Colágeno/fisiología , Fibronectinas/fisiología , Laminina/fisiología , Vitronectina/fisiología
6.
Braz. j. med. biol. res ; 34(6): 699-709, Jun. 2001. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-285842

RESUMEN

The anticlotting and antithrombotic activities of heparin, heparan sulfate, low molecular weight heparins, heparin and heparin-like compounds from various sources used in clinical practice or under development are briefly reviewed. Heparin isolated from shrimp mimics the pharmacological activities of low molecular weight heparins. A heparan sulfate from Artemia franciscana and a dermatan sulfate from tuna fish show a potent heparin cofactor II activity. A heparan sulfate derived from bovine pancreas has a potent antithrombotic activity in an arterial and venous thrombosis model with a negligible activity upon the serine proteases of the coagulation cascade. It is suggested that the antithrombotic activity of heparin and other antithrombotic agents is due at least in part to their action on endothelial cells stimulating the synthesis of an antithrombotic heparan sulfate.


Asunto(s)
Humanos , Animales , Bovinos , Anticoagulantes/farmacología , Endotelio Vascular/citología , Fibrinolíticos/farmacología , Heparina/farmacología , Heparitina Sulfato/farmacología , Anticoagulantes/química , Anticoagulantes/metabolismo , Crustáceos , Fibrinolíticos/química , Fibrinolíticos/metabolismo , Glicosaminoglicanos/metabolismo , Glicosaminoglicanos/farmacología , Heparina de Bajo-Peso-Molecular/química , Heparina de Bajo-Peso-Molecular/metabolismo , Heparina de Bajo-Peso-Molecular/farmacología , Heparina/metabolismo , Heparitina Sulfato/biosíntesis , Atún
7.
Braz. j. med. biol. res ; 34(5): 621-626, May 2001. ilus
Artículo en Inglés | LILACS | ID: lil-285875

RESUMEN

Fucans, a family of sulfated polysaccharides present in brown seaweed, have several biological activities. Their use as drugs would offer the advantage of no potential risk of contamination with viruses or particles such as prions. A fucan prepared from Spatoglossum schröederi was tested as a possible inhibitor of cell-matrix interactions using wild-type Chinese hamster ovary cells (CHO-K1) and the mutant type deficient in xylosyltransferase (CHO-745). The effect of this polymer on adhesion properties with specific extracellular matrix components was studied using several matrix proteins as substrates for cell attachment. Treatment with the polymer inhibited the adhesion of fibronectin to both CHO-K1 (2 x 10(5))()and CHO-745 (2 x 10(5) and 5 x 10(5)) cells. No effect was detected with laminin, using the two cell types. On the other hand, adhesion to vitronectin was inhibited in CHO-K1 cells and adhesion to type I collagen was inhibited in CHO-745 cells. In spite of this inhibition, the fucan did not affect either cell proliferation or cell cycle. These results demonstrate that this polymer is a new anti-adhesive compound with potential pharmacological applications


Asunto(s)
Animales , Cricetinae , Anticoagulantes/química , Adhesión Celular/efectos de los fármacos , Proteínas de la Matriz Extracelular/química , Polisacáridos/química , Algas Marinas/química , Anticoagulantes/farmacología , Ciclo Celular , División Celular/efectos de los fármacos , Células CHO , Proteínas de la Matriz Extracelular/antagonistas & inhibidores , Polisacáridos/farmacología , Timidina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA